Diseases, Conditions, Syndromes

U.S. to buy $1 billion worth of rapid COVID tests

The Biden administration said Wednesday that it plans to purchase $1 billion worth of rapid, at-home coronavirus tests and take other actions to quadruple the number of tests available to Americans by December.

Medical research

No particular risk of infection of SARS-CoV-2 from cash

How long do coronaviruses remain infectious on banknotes and coins? Is it possible to become infected through contact with cash? Experts at the European Central Bank, in collaboration with the Department of Medical and Molecular ...

Diseases, Conditions, Syndromes

Researchers develop more reliable rapid tests for COVID-19

Researchers at the University of Maryland School of Medicine (UMSOM) have developed two rapid diagnostic tests for COVID-19 that are nearly as accurate as the gold-standard test currently used in laboratories. Unlike the ...

Medical research

A new rapid test detects a coronavirus infection in 10 minutes

An antigen-based detection technique developed by University of Helsinki researchers could be used to analyze as many as 500 samples per hour. In a recently completed study, the rapid test was able to diagnose a viral infection ...

Diseases, Conditions, Syndromes

Rapid COVID tests used twice weekly could detect most contagious kids

Last year, the U.S. government purchased 150 million BinaxNOW rapid antigen COVID-19 tests and began distributing them. One of the goals was to safely reopen schools. However, little data was available on how well these tests ...

Diseases, Conditions, Syndromes

Rapid antigen testing for COVID-19: Piecing the puzzle together

A new study from Boston Children's Hospital and the Massachusetts Department of Health compared one of the latest rapid antigen tests for COVID-19—the Abbott BinaxNOW—with a highly accurate PCR test in a high-volume, ...

Diseases, Conditions, Syndromes

Arizona economic burden of valley fever totals $736 million

A University of Arizona Health Sciences study has estimated total lifetime costs at $736 million for the 10,359 valley fever patients diagnosed in Arizona in 2019, underscoring the economic burden the disease places on the ...

page 8 from 23